CURE Pharmaceutical just announced the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm®, one of the most advanced oral thin films on the market today. The new line adds CUREpods™ chewables and emulsions to meet increased demand for alternative dosage forms that can improve solubility and absorption.
“Building on the market demand for CUREfilm for nutraceutical and pharmaceutical applications, we are expanding our oral formulation platform to redefine how medications are delivered and experienced,” said Rob Davidson, CEO of CURE Pharmaceutical. “We are broadening our manufacturing footprint due to growing market awareness for our ability to deliver formulations at scale.”
Read the full announcement: CURE Pharmaceutical Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions (GlobeNewswire)
Read additional coverage here.
